Chase AIPricingFAQs
Display currency
Loading news…

Aegera Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Montréal, Quebec, Canada Founded 1997 11-50 employees For Profit

Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.

Aegera Therapeutics was acquired by Pharmascience in 2011.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
2
Patents
6

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Patents granted
6
Trademarks
0
Top patent class
Organic Chemistry
IT spend
$486K

Company Info

Founded
1997
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
1
HQ
Montréal, Quebec, Canada
Exit date
May 27, 2011
Closed
Sep 20, 2011

Signals & Scores

Heat score
Low
Trend (7d)
3.7
Trend (30d)
4.6
Trend (90d)
3

Acquisitions by Aegera Therapeutics

Loading columns…
0 of 0Show
Page 1 / 1
2
professional contacts at Aegera Therapeutics
Contact execs at Aegera Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Aegera Therapeutics

Loading news…

FAQs about Aegera Therapeutics

People who checked this page also checked these

Sectors Aegera Therapeutics invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Aegera Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments